
Delta9-tetrahydrocannabivarin beneficial in type 2 diabetes
(HealthDay)—For patients with non-insulin-treated type 2 diabetes, Δ9-tetrahydrocannabivarin (THCV) reduces fasting plasma glucose, and improves pancreatic β-cell function, adiponectin, and apolipoprotein A, according ...
Sep 1, 2016
0
1